Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Ticagrelor in Chinese Stable CAD
NCT02514642Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Jul 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by The First Affiliated Hospital of Harbin Medical University. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02514642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02514642.